State Street Portfolio holdings
State Street Corporation, established in 1792 and headquartered in Boston, Massachusetts, is one of the oldest financial institutions in the United States and a major player in the global asset management and custody banking sectors. Primarily known for its custodial services, it safeguards assets for institutional investors, managing trillions of dollars through its State Street Global Advisors (SSGA) division, which is renowned for launching the first U.S. exchange-traded fund (ETF), the SPDR S&P 500 ETF (SPY), in 1993. The company provides a range of services including investment management, research, trading, and data analytics, catering mostly to institutional clients like pension funds, endowments, and mutual funds. With a focus on financial infrastructure and innovation, State Street has positioned itself as a key backbone in the global investment ecosystem.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Otis Worldwide
OTIS
|
+$1.81B |
| 2 |
Carrier Global
CARR
|
+$1.35B |
| 3 |
AbbVie
ABBV
|
+$1.01B |
| 4 |
T-Mobile US
TMUS
|
+$760M |
| 5 |
Blackrock
BLK
|
+$755M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.43B |
| 2 |
RTN
Raytheon Company
RTN
|
+$1.53B |
| 3 |
RTX Corp
RTX
|
+$1.04B |
| 4 |
Apple
AAPL
|
+$1.02B |
| 5 |
Bank of America
BAC
|
+$384M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.65% |
| 2 | Healthcare | 14.48% |
| 3 | Financials | 12.68% |
| 4 | Consumer Discretionary | 10.62% |
| 5 | Industrials | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
iShares Europe ETF
IEV
$1.7B
| $4.98M | ﹤0.01% |
123,293
-62,011
| -33% | -$2.36M |
|
|
CBAY
2652
DELISTED
Cymabay Therapeutics
CBAY
| $4.94M | ﹤0.01% |
1,414,471
-7,095
| -0.5% | -$20.5K |
|
2653
Ternium
TX
$10.6B
| $4.93M | ﹤0.01% |
325,255
-79,162
| -20% | -$1.14M |
|
2654
Franklin Covey
FC
$246M
| $4.93M | ﹤0.01% |
230,457
+23,816
| +12% | +$483K |
|
|
FRG
2655
DELISTED
Franchise Group, Inc.
FRG
| $4.92M | ﹤0.01% |
+224,816
| New | +$3.59M |
|
2656
Home Bancorp
HBCP
$566M
| $4.91M | ﹤0.01% |
183,475
+20,138
| +12% | +$493K |
|
2657
Citi Trends
CTRN
$605M
| $4.91M | ﹤0.01% |
242,575
-4,343
| -2% | -$56.9K |
|
2658
Philips
PHG
$26.1B
| $4.9M | ﹤0.01% |
126,646
+50,220
| +66% | +$1.75M |
|
|
TDAY
2659
USA Today Co
TDAY
$1.06B
| $4.9M | ﹤0.01% |
3,547,481
-596,515
| -14% | -$786K |
|
|
SLY
2660
DELISTED
SPDR S&P 600 Small Cap ETF (based on S&P SmallCap 600 Index--symbol SML)
SLY
| $4.89M | ﹤0.01% |
82,882
-72,211
| -47% | -$3.94M |
|
2661
Wave Life Sciences
WVE
$1.2B
| $4.88M | ﹤0.01% |
469,081
-40,155
| -8% | -$378K |
|
2662
HF Foods Group
HFFG
$83.4M
| $4.88M | ﹤0.01% |
538,881
+198,830
| +58% | +$1.45M |
|
2663
Metallus
MTUS
$898M
| $4.87M | ﹤0.01% |
1,251,420
-72,939
| -6% | -$244K |
|
2664
Lindblad Expeditions
LIND
$2.22B
| $4.86M | ﹤0.01% |
629,198
+10,377
| +2% | +$71.6K |
|
2665
Citizens & Northern Corp
CZNC
$455M
| $4.85M | ﹤0.01% |
234,716
+9,015
| +4% | +$170K |
|
2666
AstraZeneca
AZN
$250B
| $4.83M | ﹤0.01% |
45,698
+2,704
| +6% | +$279K |
|
|
CNCE
2667
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $4.82M | ﹤0.01% |
484,709
+15,689
| +3% | +$150K |
|
2668
Rayonier Advanced Materials
RYAM
$610M
| $4.81M | ﹤0.01% |
1,711,709
-27,180
| -2% | -$52.1K |
|
2669
Forestar Group
FOR
$1.51B
| $4.78M | ﹤0.01% |
316,672
+31,961
| +11% | +$440K |
|
2670
Aprea Therapeutics
APRE
$7.83M
| $4.77M | ﹤0.01% |
6,147
+583
| +10% | +$383K |
|
2671
Mercer International
MERC
$39.8M
| $4.75M | ﹤0.01% |
577,560
+3,126
| +0.5% | +$26.1K |
|
|
EXTN
2672
DELISTED
Exterran Corporation
EXTN
| $4.75M | ﹤0.01% |
880,408
-188,235
| -18% | -$1.07M |
|
|
BCLI
2673
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $4.74M | ﹤0.01% |
+28,179
| New | +$3.04M |
|
|
MCBC
2674
DELISTED
Macatawa Bank Corp
MCBC
| $4.74M | ﹤0.01% |
605,941
+3,351
| +0.6% | +$24.3K |
|
2675
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.55B
| $4.73M | ﹤0.01% |
133,240
-6,920
| -5% | -$223K |
|
Similar funds
State Street's Q2 2020 Portfolio in Review
As of Q2 2020, State Street held 3,952 positions worth $1.38T, up 20% from $1.14T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
State Street's Q2 2020 filing shows 183 new, 1,998 increased, 1,421 reduced and 249 closed positions. Its largest new stake was Otis Worldwide: 34,962,166 shares worth $1.99B. The largest sale was Allergan plc, an estimated $2.43B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- State Street's largest Q2 2020 buy was Otis Worldwide: 34,962,166 shares worth $1.99B.
- State Street added most to AbbVie in Q2 2020, an estimated $1.01B increase.
- State Street's biggest Q2 2020 reduction was RTX Corp, cutting an estimated $1.04B.
- State Street fully exited Allergan plc in Q2 2020, selling an estimated $2.43B.
- State Street's ten largest holdings make up 21% of its $1.38T portfolio in Q2 2020.
- State Street opened 183 new positions and closed 249 in Q2 2020.
- State Street's portfolio value rose 20% quarter-over-quarter to $1.38T.
Based on State Street's 13F filing for Q2 2020, filed 14 Aug 2020.